21st August 2018: A new chapter in the provision of advanced cancer care in the North-East of England has started with the official opening of the Rutherford Cancer Centre North East.
8th August 2018: The provision of advanced cancer treatment in the South of England passed a key milestone today with the arrival of the first high energy proton beam therapy system in the region.
7th August 2018: The first patient to be treated with high energy proton beam therapy for breast cancer in the UK commenced treatment this week at the Rutherford Cancer Centre South Wales.
11th April 2018: Proton Partners International announced today it has treated the first patient in the UK with high energy proton beam therapy.
20th March 2018: Proton Partners International has been granted formal technical and regulatory approval from Healthcare Inspectorate Wales to begin treating patients with proton beam therapy at its Rutherford Cancer Centre in Wales.
12th March 2018: IBA, the world’s leading provider of proton therapy solutions for the treatment of cancer, today announces it has signed three new contracts with Proton Partners International, to install three Proteus®ONE* compact proton therapy solutions across the UK.
7th March 2018: Wales has shown ‘outstanding’ vision in helping to develop innovative proton beam therapy services for cancer patients.
22nd February 2018: Proton Partners International and Ion Beam Applications (IBA) Group, the world’s leading developers of high energy proton beam therapy centres and systems, have officially completed testing on the UK’s first high energy proton beam machine, the Proteus®ONE.
6th February 2018: The first proton beam therapy system to be installed in the North-East of England was delivered today by Proton Partners International Ltd.
Proton Partners International and Ion Beam Applications (IBA) Group, the world’s leading developers of high energy proton beam therapy centres and systems, have officially completed testing on the UK’s first high energy proton beam machine, the Proteus®ONE.
The official completion and acceptance of testing took place at the landmark Rutherford Cancer Centre in Newport, South Wales. This is the fastest installation of a proton therapy centre to date. The centre will bring the most advanced treatments in cancer care to South Wales and will start treating patients with high energy proton beam therapy in March.
The single room Proteus®ONE proton beam therapy system, installed and maintained by IBA, offers the most advanced proton therapy technology on the market. Its compact design makes it easy to install, integrate, operate, and finance.
The system has a unique open gantry environment designed to ease the treatment workflow of the radiographers and to optimise the patient experience by providing a comfortable and calming environment. The system is equipped with Pencil Beam Scanning, which enables a highly precise scanning to minimise radiation exposure to healthy tissue. Proteus®ONE is much more compact than large multi-room system while bringing the latest technology in the room to ensure the most precise and efficient treatment possible.
Mike Moran, chief executive officer of Proton Partners International, said: “We are thrilled that the UK’s first proton beam therapy system has been approved for treatment at our Rutherford Cancer Centre in Newport. Through working with IBA we have ensured that our centres are equipped with the latest cancer technology and we are extremely proud to be at the forefront of delivering innovative cancer treatment.”
Luk Herremans, Senior Vice President of IBA Proton Therapy, said: “We are proud that acceptance testing has been completed within 9 months since the delivery of the cyclotron, a new world record. With Proteus®ONE, IBA makes proton beam therapy accessible to cancer patients at the Rutherford centre in Newport from March. We will continue to support Proton Partners International at each of their Rutherford centres as they transform cancer treatment for thousands of patients across the UK.”
The facility will treat up to 500 cancer patients a year and the Proteus®ONE system will also be installed at each of the Rutherford Cancer Centres being built in the UK. Three more UK centres are currently under development, one in Northumberland, Reading and Liverpool.